(R)-carnitine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases HDL cholesterol
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Finding“The subjects in the LC group had significantly higher level of HDL-C (1.34 ± 0.42 vs. 1.16 ± 0.24 mmol/L, P = 0.03) and Apo-A1 (1.24 ± 0.18 vs. 1.12 ± 0.13 g/L, P = 0.02) than those in the placebo group at week 12.”
Quoted verbatim from Effects of L-carnitine supplementation on lipid profiles in patients with coronary artery disease.. - Study
- RCT
- Duration
- 3 months
- Dose
- 1000 mg/day L-carnitine as 500 mg twice daily for 12 weeks
- Population
- Male patients with coronary artery disease (at least 50% stenosis of a major coronary artery), 39 completers, week 12 values compared with starch placebo; single-blind
Effects of L-carnitine supplementation on lipid profiles in patients with coronary artery disease.2016PMID:27317162Permalink
Keep reading
- Everything the graph holds on (R)-carnitine
- Every compound studied against HDL cholesterol
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5RXEJ0E0FVZRZ3P506FHM3X